Long-Term Results of Edge-to-Edge Mitral Valve Repair in Degenerative Mitral Valve Disease: A Single-Center Experience
Konstantinos Sideris, Melchior Burri, Anatol Prinzing, Marcus Krane, Ralf Guenzinger, Ramon L. Lange, B. Voss
Abstract
Konstantinos Sideris, Melchior Burri, Anatol Prinzing, Marcus Krane, Ralf Guenzinger, Ramon L. Lange, B. Voss
Abstract
All articles of this category Objectives: Different sophisticated repair techniques have been established for the tailored treatment of primary mitral regurgitation. The Edge-to-Edge mitral valve repair has been somehow discredited in the past but has seen a revival recently for complicated Barlow disease. The aim of the present study was to assess the long-term results of this repair technique. Methods: Between March 1999 and July 2019, a total of 153 patients (mean age, 60 ± 12.9 years), received an edge-to-edge repair and annuloplasty for regurgitation in degenerative mitral valve disease at our institution. Mitral regurgitation resulted from posterior leaflet prolapse in 23 patients (15%), anterior leaflet prolapse in 19 patients (12.4%), and bileaflet prolapse in 111 patients (72.6%). Of those who had a prolapse of both leaflets, 92 had a Barlow’s disease. Follow-up was complete in 96.1% (mean, 6.3 ± 5.7 years; longest duration, 18.4 years). Echocardiographic assessment was achieved in 85.5% (mean, 5.1 ± 5.6 years; median, 1.6 years; range from 30 days to 18.4 years). Preoperative, periprocedural and postoperative data were prospectively collected in a dedicated database and analyzed retrospectively. Results: A 30-day mortality was 0.6%. At 10 years, the overall survival was 73.4 ± 5.1%, and the cumulative incidence of valve related reoperation was 5.1 ± 2.5%. During follow-up, 10 patients required a mitral valve-related reoperation due to ring dehiscence ( n = 2), leaflet suture dehiscence ( n = 2), and progression of native valve disease ( n = 6). Additionally, two patients required reoperation due to device failure (ring fracture) which were not included in the analysis. At latest echocardiographic follow-up three patients presented with more than moderate mitral regurgitation. The mean pressure gradient across the mitral valve was 2.9 ± 1.3 mm Hg at discharge and 2.4 ± 1.3 mm Hg at latest echocardiographic follow-up. Nearly all (140 of 147, 95.2%) patients were in New York Heart Association (NYHA) class I or II. Conclusion: Edge-to-Edge mitral valve repair is a simple and reproducible method with excellent long-term results particular in patients with Barlow’s disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
All articles of this category Objectives: Different sophisticated repair techniques have been established for the tailored treatment of primary mitral regurgitation. The Edge-to-Edge mitral valve repair has been somehow discredited in the past but has seen a revival recently for complicated Barlow disease. The aim of the present study was to assess the long-term results of this repair technique. Methods: Between March 1999 and July 2019, a total of 153 patients (mean age, 60 ± 12.9 years), received an edge-to-edge repair and annuloplasty for regurgitation in degenerative mitral valve disease at our institution. Mitral regurgitation resulted from posterior leaflet prolapse in 23 patients (15%), anterior leaflet prolapse in 19 patients (12.4%), and bileaflet prolapse in 111 patients (72.6%). Of those who had a prolapse of both leaflets, 92 had a Barlow’s disease. Follow-up was complete in 96.1% (mean, 6.3 ± 5.7 years; longest duration, 18.4 years). Echocardiographic assessment was achieved in 85.5% (mean, 5.1 ± 5.6 years; median, 1.6 years; range from 30 days to 18.4 years). Preoperative, periprocedural and postoperative data were prospectively collected in a dedicated database and analyzed retrospectively. Results: A 30-day mortality was 0.6%. At 10 years, the overall survival was 73.4 ± 5.1%, and the cumulative incidence of valve related reoperation was 5.1 ± 2.5%. During follow-up, 10 patients required a mitral valve-related reoperation due to ring dehiscence ( n = 2), leaflet suture dehiscence ( n = 2), and progression of native valve disease ( n = 6). Additionally, two patients required reoperation due to device failure (ring fracture) which were not included in the analysis. At latest echocardiographic follow-up three patients presented with more than moderate mitral regurgitation. The mean pressure gradient across the mitral valve was 2.9 ± 1.3 mm Hg at discharge and 2.4 ± 1.3 mm Hg at latest echocardiographic follow-up. Nearly all (140 of 147, 95.2%) patients were in New York Heart Association (NYHA) class I or II. Conclusion: Edge-to-Edge mitral valve repair is a simple and reproducible method with excellent long-term results particular in patients with Barlow’s disease.
Key concepts: Medicine, Mitral regurgitation, Mitral valve repair, Mitral valve, Disease, Cardiology, Functional mitral regurgitation, Surgery